John Burn
Impact in
- Pathology and Forensic Medicine top 0.05%
- Genetic factors in colorectal cancer
- Genetics top 0.2%
- Genomic variations and chromosomal abnormalities
- Genomics and Rare Diseases
- BRCA gene mutations in cancer
Papers in
-
- Genetic factors in colorectal cancer 125
- Genetics 123
- Genomics and Rare Diseases 43
- Genomic variations and chromosomal abnormalities 38
- BRCA gene mutations in cancer 15
- Genetic and rare skin diseases. 13
- Co-authors
- Judith Goodship (16 shared papers)David I. Wilson (19 shared papers)Peter James Scambler (20 shared papers)Sally Ann Lynch (10 shared papers)I Cross (10 shared papers)Michael Baraitser (14 shared papers)I E Cross (5 shared papers)Mary E. Porteous (7 shared papers)
- Journals
- Journal of Medical Genetics (60 papers)The Lancet (15 papers)Gut (12 papers)The American Journal of Human Genetics (11 papers)Nature Genetics (11 papers)
- Partner nations
- United KingdomUnited StatesGermany
In The Last Decade
John Burn
395 papers receiving 26.5k citations
John Burn's Hit Papers
Peers
Comparison fields: 5 of 170
- Pathology and Forensic Medicine 6.3k
- Genetics 6.7k
- Developmental Biology 469
- Pharmacology 1.7k
- Oncology 2k
Countries citing papers authored by John Burn
This map shows the geographic impact of John Burn's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John Burn with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John Burn more than expected).
Fields of papers citing papers by John Burn
This network shows the impact of papers produced by John Burn. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John Burn. The network helps show where John Burn may publish in the future.
Co-authors
The 25 scholars most cited alongside John Burn, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 404 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Celecoxib for the Prevention of Sporadic Colorectal Adenomas Hit paper breakdown → | 2006 | 900 |
| 2 | Long-term effect of aspirin on cancer risk in carriers of hereditary colorectal cancer: an analysis from the CAPP2 randomised controlled trial Hit paper breakdown → | 2011 | 781 |
| 3 | Aspirin and non-steroidal anti-inflammatory drugs for cancer prevention: an international consensus statement Hit paper breakdown → | 2009 | 624 |
| 4 | Identification of the familial cylindromatosis tumour-suppressor gene Hit paper breakdown → | 2000 | 583 |
| 5 | Revised guidelines for the clinical management of Lynch syndrome (HNPCC): recommendations by a group of European experts Hit paper breakdown → | 2013 | 581 |
| 6 | Peutz–Jeghers syndrome: a systematic review and recommendations for management Hit paper breakdown → | 2010 | 535 |
| 7 | Guidelines for the clinical management of familial adenomatous polyposis (FAP) Hit paper breakdown → | 2008 | 528 |
| 8 | Cancer risks by gene, age, and gender in 6350 carriers of pathogenic mismatch repair variants: findings from the Prospective Lynch Syndrome Database Hit paper breakdown → | 2019 | 488 |
| 9 | 2001 | 463 | |
| 10 | Cancer risk and survival in path_MMR carriers by gene and gender up to 75 years of age: a report from the Prospective Lynch Syndrome Database Hit paper breakdown → | 2017 | 454 |
| 11 | Cancer incidence and survival in Lynch syndrome patients receiving colonoscopic and gynaecological surveillance: first report from the prospective Lynch syndrome database Hit paper breakdown → | 2015 | 448 |
| 12 | 2007 | 423 | |
| 13 | Whole-genome sequencing of patients with rare diseases in a national health system Hit paper breakdown → | 2020 | 418 |
| 14 | Evidence for 28 genetic disorders discovered by combining healthcare and research data Hit paper breakdown → | 2020 | 417 |
| 15 | 1993 | 412 | |
| 16 | 2000 | 386 | |
| 17 | 1992 | 357 | |
| 18 | 1997 | 345 | |
| 19 | 2010 | 328 | |
| 20 | 1998 | 308 |
About John Burn
John Burn is a scholar working on Pathology and Forensic Medicine, Genetics, Pharmacology, Pediatrics, Perinatology and Child Health and Developmental Biology, having authored 404 papers that have together received 27.7k indexed citations. Recurring topics across this work include Genetic factors in colorectal cancer (125 papers), Genomics and Rare Diseases (43 papers), Genomic variations and chromosomal abnormalities (38 papers), Inflammatory mediators and NSAID effects (25 papers), Congenital heart defects research (19 papers), Congenital Heart Disease Studies (17 papers), BRCA gene mutations in cancer (15 papers) and Genetic and rare skin diseases. (13 papers). The work is most often cited by research in Pathology and Forensic Medicine (6.3k citations), Genetics (6.7k citations), Developmental Biology (469 citations), Pharmacology (1.7k citations) and Oncology (2k citations). John Burn has collaborated with scholars based in United Kingdom, United States and Germany. Frequent co-authors include Judith Goodship, David I. Wilson, Peter James Scambler, Sally Ann Lynch, I Cross, Michael Baraitser, I E Cross, Mary E. Porteous, John Cummings Mathers and Patrick Francis Chinnery. Their work appears in journals such as Journal of Medical Genetics, The Lancet, Gut, The American Journal of Human Genetics and Nature Genetics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.